Results 81 to 90 of about 33,059 (231)

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population. Aim To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV
Antros Louca   +13 more
wiley   +1 more source

The roadmap to transcatheter aortic valve implantation

open access: yesRevista Portuguesa de Cardiologia, 2023
Nearly 300 years after the first description of aortic valve obstruction, it has taken less than two decades of randomized clinical trials (RCTs) for transcatheter aortic valve implantation (TAVI) to become a recognized strategy for patients with aortic stenosis.
Joel, Ponte Monteiro   +5 more
openaire   +2 more sources

Balloon Aortic Valvuloplasty as Bridge-to-Decision in High Risk Patients with Severe Aortic Valve Stenosis [PDF]

open access: yes, 2015
Background. A sizable group of patients with symptomatic aortic stenosis (AS) can undergo neither surgical aortic valve replacement (AVR) nor transcatheter aortic valve implantation (TAVI) because of clinical contraindications.
Bordoni, Barbara <1980>
core   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié   +8 more
wiley   +1 more source

Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes [PDF]

open access: yes, 2017
Background: Transcarotid access is an alternative route for transcutaneous aortic valve implantation (TAVI) in patients with impossible transfemoral access.Aims: We evaluated the safety, effectiveness and early and late clinical outcomes of CoreValve®
Berger, Alexandre   +10 more
core   +1 more source

Three‐Cusp View Orientation in TAVI: Evaluating LOA Versus Non‐LOA Impact on Outcomes With Contemporary Valve Prostheses

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Optimal projection views during transcatheter aortic valve implantation (TAVI) procedures are critical for procedural success and patient outcomes. Aims This study investigated the influence of 3‐cusp view orientation—line of alignment (LOA) versus non‐LOA—on procedural outcomes in patients undergoing TAVI with contemporary ...
Rim Kasem Ali Sliman   +5 more
wiley   +1 more source

Echocardiography for transcatheter aortic valve implantation [PDF]

open access: yesEuropean Journal of Echocardiography, 2009
Transcatheter aortic valve implantation (TAVI) is a new technology that treats severe aortic stenosis. The technology has specific and mandatory technical requirements that must be met to allow safe and successful procedures. The echocardiographic method for diagnosis of aortic stenosis, anatomical case selection, procedural guidance and management of ...
openaire   +3 more sources

Reoperative aortic valve replacement in the era of valve‐in‐valve procedures

open access: yesClinical Case Reports, 2020
Current evidence suggests that the choice between valve‐in‐valve transcatheter aortic valve implantation and reoperative aortic valve replacement should be based on multiple factors.
Daisuke Kaneyuki   +3 more
doaj   +1 more source

Computer Vision Techniques for Transcatheter Intervention [PDF]

open access: yes, 2015
Minimally invasive transcatheter technologies have demonstrated substantial promise for the diagnosis and treatment of cardiovascular diseases. For example, TAVI is an alternative to AVR for the treatment of severe aortic stenosis and TAFA is widely used
Matt Roach, Xianghua Xie
core   +1 more source

Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The recent voluntary withdrawal of the ACURATE neo2 transcatheter aortic valve replacement device by Boston Scientific offers a compelling case study in the complex interplay of device design, clinical evidence, regulatory requirements, and market dynamics in modern structural heart interventions.
Arturo Giordano   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy